{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-004203","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.676273+00:00","generated_at":"2026-06-19T06:12:55.403465+00:00","sec_items":["1.01","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Windtree Therapeutics enters warrant inducement agreement; receives ~$157K from exercise of existing warrants","bullets":["Reduced exercise price of existing warrants to $0.1411 per share; holder exercises 1,112,308 shares for ~$157K.","Issued new warrants to purchase up to 2,224,616 shares at $0.2152, exercisable after 6 months, expiring 5 years later.","Engaged Ladenburg Thalmann as placement agent; fees of 8% of gross proceeds plus 1% management fee.","New warrants have 19.99% beneficial ownership limitation; resale registration statement to be filed within 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-004203","json":"https://secwatch.observer/filing/0001437749-23-004203.json","markdown":"https://secwatch.observer/filing/0001437749-23-004203.md","text":"https://secwatch.observer/filing/0001437749-23-004203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774923004203/0001437749-23-004203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774923004203/wint20230222_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T06:12:55.403465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cbe6cfcc98c16b3f1092f86b23c736707ed30f26","claim":"WINDTREE THERAPEUTICS INC /DE/ entered into Inducement Letter with a certain holder (the \"Exercising Holder\") valued at approximately $157,000 (effective 2023-02-21).","evidence_excerpt":"On February 21, 2023, Windtree Therapeutics, Inc. (the \"Company\") entered into a warrant exercise inducement offer letter (the \"Inducement Letter\") with a certain holder (the \"Exercising Holder\") of certain of the Company’s: (i) warrants issued in July 2018 to purchase 62,500 shares of common stock, par value $0.001 per share (\"Common Stock\"), with an exercise price of $12.00 per share (the \"July 2018 Warrants\"); (ii) warrants issued in December 2018 to purchase 498,008 shares of Common Stock with an exercise price of $12.15 per share (the \"December 2018 Warrants\"); (iii) warrants issued in December 2019 to purchase 275,938 shares of Common Stock with an exercise price of $12.09 per share (the \"December 2019 Warrants\"); and (iv) warrants issued in May 2020 to purchase 275,862 shares of Common Stock with an exercise price of $7.975 per share (the \"May 2020 Warrants\", and together with the July 2018 Warrants, December 2018 Warrants and December 2019 Warrants, the \"Existing Warrants\").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923004203/0001437749-23-004203-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain holder (the \"Exercising Holder\")"},{"label":"Value","value":"approximately $157,000"},{"label":"Effective","value":"2023-02-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}